Joincare Pharmaceutical Group Industry Co., Ltd. Provides Earnings Guidance for the Full Year of 2017
January 11, 2018
Share
Joincare Pharmaceutical Group Industry Co. Ltd. provided earnings guidance for the full year of 2017. For the year, the company predicts that the net profit belonging to shareholders will increase by between RMB 1,636 million and RMB 1,733 million with an increase of between 362.51% and 383.92% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders after excluding extraordinary profit and loss will increase by between RMB 151 million and RMB 197 million with an increase of between 47.80% and 62.59% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).
Joincare Pharmaceutical Group Industry Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals and healthcare products. The Company's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The Company is also engaged in electricity business. The Company distributes its products within domestic market and to overseas markets.